SCHEMBL19999728

SCHEMBL19999728

CO/C=C/c1ccc(C)cc1OCc1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 1/20 0.48
PTGER1 P34995 4/20 0.46
PTGER4 P35408 4/20 0.46
PTGER3 P43115 4/20 0.46
PTGER2 P43116 4/20 0.46
CCNB2 O95067 1/20 0.46
CDK1 P06493 1/20 0.46
CDK4 P11802 1/20 0.46
CCNB1 P14635 1/20 0.46
CCND1 P24385 1/20 0.46
CCNB3 Q8WWL7 1/20 0.46
MAPT P10636 2/20 0.45
MAPK1 P28482 1/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
STAT3 P40763 1/20 0.43
HTT P42858 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MAOB P27338 4/20 0.43
MRGPRX4 Q96LA9 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19999733 0.85 CCNB2 (0.48) HDAC8PTGER1PTGER4PTGER3PTGER2
SCHEMBL20006886 0.84 HDAC8 (0.66) HDAC8MAPTHTTSMN1; SMN2MAOB
SCHEMBL7229336 0.83 CDK4 (0.68) HDAC8PTGER1PTGER4PTGER3PTGER2
SCHEMBL7229340 0.83 CDK4 (0.68) HDAC8PTGER1PTGER4PTGER3PTGER2
SCHEMBL20359857 0.81 MAPT (0.49) HDAC8PTGER1PTGER4PTGER3PTGER2
SCHEMBL8322912 0.81 MAPT (0.49) HDAC8PTGER1PTGER4PTGER3PTGER2
SCHEMBL3035265 0.81 MAPT (0.50) HDAC8PTGER1PTGER4PTGER3PTGER2
SCHEMBL28505728 0.80 PTGER1 (0.43) HDAC8PTGER1PTGER4PTGER3PTGER2
SCHEMBL28506994 0.80 PTGER1 (0.43) HDAC8PTGER1PTGER4PTGER3PTGER2
SCHEMBL15248918 0.77 HDAC8 (0.60) HDAC8PTGER1PTGER4PTGER3PTGER2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180086772-A1 MEDICARPIN, ITS DERIVATIVES, MANUFACTURING METHOD THEREOF PHYTOHEALTH CORPORATION (TW) 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180086772-A1 MEDICARPIN, ITS DERIVATIVES, MANUFACTURING METHOD THEREOF SHARPIN, TIPARP, MYADM HDAC8 4603/4885PTGER1 1548/4885PTGER4 2004/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.